Table 11.
Substrate (preferentially for) | Skin | Keratinocytesb | HaCaT | NCTC 2544 | KeratinoSens® | LuSens | U937 | THP-1 |
---|---|---|---|---|---|---|---|---|
Benzydamine (broad-spectrum FMO substrate) | + | bd | bd | bd | bd | |||
Arachidonic acid (COX) | 23.5 ± 8.7c | 5.1 ± 2.8c | 0.05 ± 0.03c | 0.02 ± 0.01c | ||||
Ethanol (ADH) | 0.3–0.4d | bd | bq | bd | bq | |||
Propanal (ALDH) | 8 ± 1.5m | 4.77–16.4d | 8.04–17.3d | bd | bq | |||
2,6-Dichlorophenol indophenol (NQR) | ~350d |
~340d,e ~880/1320d,f |
134 ± 0.05d | |||||
Menadione (NQR) | 7–10d/~ 11d,g | ~88d | ~288d | |||||
Fluorescein diacetate (E) | ~0.5h | 3.7h | 3.20–4.06h | 1.19–3.55h | 0.911–1.057h | 0.869–1.072h | ||
4-MU heptanoate (E) | 10–32j | 23j | ||||||
CDNB (GST) | ~290f,j | ~620d; ~50j | ~47j |
~40m 167 ± 3m/234m |
||||
Para-nitrophenol (UGT) | 0.016–0.023j | |||||||
4-MU (UGT) | 1.3 ± 0.2k | bd to ~1.2j | 1.99 ± 0.97j | ~1j | bd | bd | bd | bd |
PABA (NAT) | 0.449 ± 0.175h |
0.215 ± 0.070h 8 ± 0.5l |
12.0–44.5l | 13.3–28.7h | 10.9–22.6h | 24.8–60.2h | 6.00–29.9h | |
Para-toluidine (NAT) | 0.63–3.03d | 0.16 ± 0.08j | 0.65 ± 0.37j | 0.35 ± 0.22j |
More examples and references in the text
4-MU 4-methylumbelliferone, ADH alcohol dehydrogenase, ALDH aldehyde dehydrogenase, DCNB 1-chloro-2,4-dinitrobenzene; E esterase, FMO flavin-dependent monooxygenase, bd below the limit of detection, bq below the limit of quantification, NQR NADH/NADPH quinone reductase, PABA para-aminobenzoic acid
aConstitutive; number after slash: induced (highest reported induced activity)
bKeratinocytes = Primary keratinocytes in culture (“NHEC,” “normal human epithelial keratinocytes”)
cpg prostaglandin E2 formed/min/mg microsomal protein
dnmol/min/mg cytosolic protein
eDifferentiated keratinocytes
fProliferating keratinocytes
gEx vivo epidermis
hnmol/min/mg S9 protein
iEpidermis (scraped from skin surgical samples)
jnmol/min/mg protein, activity determined in culture medium
knmol/min/mg microsomal protein
lnmol/min/mg cell lysate protein
mnmol/min/mg homogenate protein